期刊
RAPID COMMUNICATIONS IN MASS SPECTROMETRY
卷 26, 期 9, 页码 1134-1140出版社
WILEY
DOI: 10.1002/rcm.6216
关键词
-
资金
- National Center for Research Resources (NCRR) [1 UL1 RR024150]
- U.S. Public Health Service [DK40484, DK45343, DK50456, RR00585]
- American Diabetes Association [7-07-DCS-03]
- Mayo Foundation
- sanofi-aventis
RATIONALE: Sphingolipids are important components of cell membranes that serve as cell signaling molecules; ceramide plays a central role in sphingolipid metabolism. De novo ceramide biosynthesis depends on fatty acid availability, but whether muscle uses circulating free fatty acids or pre-existing intracellular stores is unknown. Our goal was to develop a method to detect the incorporation of intravenously infused [U-C-13] palmitate into intramyocellular ceramides. METHODS: We used liquid chromatography/ tandem mass spectrometry ( LC/ MS/ MS) to measure the concentrations of different sphingolipid species and C-13-isotopic enrichment of 16:0-ceramide. Chromatographic separation was performed using ultra-performance liquid chromatography. The analysis was performed on a triple quadrupole mass spectrometer using a positive ion electrospray ionization source with selected reaction monitoring (SRM). RESULTS: The sphingolipids ions, except enriched ceramide, were monitored as [M+2+H]+. The [(13)C16] 16:0-ceramide was monitored as [M+16+H](+). By monitoring two different transitions of the [(13)C16]16:0-ceramide (554/536 and 554/264) we could indirectlymeasure enrichment of the palmitate that is not a part of the sphingoid base. Concentration and enrichment could be measured using 20 mg of muscle obtained from volunteers receiving a low dose [U-C-13] palmitate infusion. CONCLUSIONS: LC/ MS/ MS can be used to detect the incorporation of plasma palmitate into muscle ceramides in humans, in vivo. Copyright (C) 2012 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据